With implants now capable of translating thoughts into words in just three seconds, the future is going to get very weird indeed.

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...

Taiwan Semiconductor Manufacturing Company (TSMC), the world’s largest contract chipmaker, is under investigation by the US ...

Life expectancy for people with metastatic or metastasized lung cancer is low. The 5-year survival rate for small cell lung cancer is 3%, and 8% for non-small cell lung cancer (NSCLC). 25-30% of ...

In particular, the main program of this company is looking at the development of nanobody Lu-RAD204 for the treatment of patients with non-small cell lung cancer [NSCLC]. In essence, a nanobody is ...

CAN-2409 showed a median overall survival of 24.5 months in NSCLC patients, with 37% of those with progressive disease alive at two years. A systemic anti-tumor response was observed in 69% of ...

An itching sensation in your lungs is often the result of irritation from allergies or environmental triggers. But it can also be a symptom of an underlying condition, like asthma, that requires ...

Email: {parthap, grecuc, ivanov, res} @ece.ubc.ca The University of British Columbia’s System-on-a-Chip (SoC) Research lab has established itself as a world-class research centre for the design, ...

Professor Jänne is one of the global leaders in the treatment of drug-resistant lung cancer and will be an important contributor to further TOLREMO’s goal of preventing non-genetic cancer drug ...